Chemical Formula: C19H21NO2

Chemical Formula C19H21NO2

Found 58 metabolite its formula value is C19H21NO2

(E)-Herclavine

(2E)-N-[2-(4-methoxyphenyl)ethyl]-N-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572206)


(E)-Herclavine is found in herbs and spices. (E)-Herclavine is an alkaloid from the bark of Zanthoxylum clava-herculis (Hercules club

   

Doxepin N-oxide

N,N-dimethyl-3-[(2E)-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propanamine oxide

C19H21NO2 (295.1572206)


Doxepin N-oxide (CAS: 22684-91-9) is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, Adapine, Doxal, Deptran, Sinquan, and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch (Wikipedia).

   

(E)-2-hydroxydoxepin

(2Z)-2-[3-(dimethylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaen-5-ol

C19H21NO2 (295.1572206)


(E)-2-hydroxydoxepin is a metabolite of doxepin. Doxepin is a psychotropic agent with tricyclic antidepressant and anxiolytic properties, known under many brand-names such as Aponal, the original preparation by Boehringer-Mannheim, now part of the Roche group; Adapine, Doxal, Deptran, Sinquan and Sinequan. As doxepin hydrochloride, it is the active ingredient in cream-based preparations (Zonalon and Xepin) for the treatment of dermatological itch. (Wikipedia)

   

1,2-Dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline

15,16-dimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaene

C19H21NO2 (295.1572206)


   

Cyclohexyl biphenyl-3-ylcarbamate

cyclohexyl N-{[1,1-biphenyl]-3-yl}carbamate

C19H21NO2 (295.1572206)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-({[2-(4-hydroxyphenyl)ethyl]amino}methyl)-1,2,3,4-tetrahydronaphthalen-1-one

C19H21NO2 (295.1572206)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

levo-tetrahydropalmatine

9,10-Dimethoxy-5,6,13,13a-tetrahydro-8H-dibenzo[a,g]quinolizine

C19H21NO2 (295.1572206)


   

N-n-Propylnorapomorphine

10-propyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,13,15-hexaene-3,4-diol

C19H21NO2 (295.1572206)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

Nuciferine

4H-DIBENZO(DE,G)QUINOLINE, 5,6,6A,7-TETRAHYDRO-1,2-DIMETHOXY-6-METHYL-, (6AR)-

C19H21NO2 (295.1572206)


CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 2317 Nuciferine is a natural product found in Cissampelos pareira, Paliurus hemsleyanus, and other organisms with data available. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor.

   
   
   
   
   
   

Carbazoquinocin A

(S)-2-Methyl-1-(3-methylpentyl)-3H-carbazole-3,4(9H)-dione

C19H21NO2 (295.1572206)


   
   
   

N-Propylnorapomorphine

N-Propylnorapomorphine

C19H21NO2 (295.1572206)


D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

URB602

[1,1-biphenyl]-3-yl-carbamic acid, cyclohexyl ester

C19H21NO2 (295.1572206)


URB602 is a selective monoacylglycerol lipase (MGL) inhibitor, which inhibits rat brain MGL with IC50 of 28±4 μM through a noncompetitive mechanism.

   
   

Noratherosperminine

Noratherosperminine

C19H21NO2 (295.1572206)


   

N-methyllaurotetanine

N-methyllaurotetanine

C19H21NO2 (295.1572206)


   
   
   

1-(2-Dimethylamino-aethyl)-3-methoxy-phenanthren-4-ol|1-<2-Dimethylamino-aethyl>-3-methoxy-phenanthren-4-ol

1-(2-Dimethylamino-aethyl)-3-methoxy-phenanthren-4-ol|1-<2-Dimethylamino-aethyl>-3-methoxy-phenanthren-4-ol

C19H21NO2 (295.1572206)


   
   
   
   
   

(E)-Herclavine

(2E)-N-[2-(4-methoxyphenyl)ethyl]-N-methyl-3-phenylprop-2-enamide

C19H21NO2 (295.1572206)


   

2-BENZOXAZOL-2-YL-1-(4-TERTBUTYLPHENYL)ETHANOL

2-BENZOXAZOL-2-YL-1-(4-TERTBUTYLPHENYL)ETHANOL

C19H21NO2 (295.1572206)


   
   

(R)-(+)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

(R)-(+)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

C19H21NO2 (295.1572206)


   

Methyl 1-benzyl-3-phenyl-3-pyrrolidinecarboxylate

Methyl 1-benzyl-3-phenyl-3-pyrrolidinecarboxylate

C19H21NO2 (295.1572206)


   

methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate

methyl 1-benzyl-4-phenylpyrrolidine-3-carboxylate

C19H21NO2 (295.1572206)


   

Benzyl N-Benzylpyrrolidine-3-carboxylate

Benzyl N-Benzylpyrrolidine-3-carboxylate

C19H21NO2 (295.1572206)


   

N-Cyclohexylcarbamic acid [1,1-biphenyl]-3-yl ester

N-Cyclohexylcarbamic acid [1,1-biphenyl]-3-yl ester

C19H21NO2 (295.1572206)


   

Ethyl 1-(diphenylmethyl)-3-azetidinecarboxylate

Ethyl 1-(diphenylmethyl)-3-azetidinecarboxylate

C19H21NO2 (295.1572206)


   

1-[4-[(4-butoxyphenyl)methylideneamino]phenyl]ethanone

1-[4-[(4-butoxyphenyl)methylideneamino]phenyl]ethanone

C19H21NO2 (295.1572206)


   

(S)-(-)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

(S)-(-)-5,5-DIPHENYL-4-ISOBUTYL-2-OXAZOLIDINONE

C19H21NO2 (295.1572206)


   

1,3-Dibenzyl-3-pyrrolidinecarboxylic acid

1,3-Dibenzyl-3-pyrrolidinecarboxylic acid

C19H21NO2 (295.1572206)


   

(S)-(-)-4-(2-CHLOROPHENYL)-2-HYDROXY-5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINANE2-OXIDE

(S)-(-)-4-(2-CHLOROPHENYL)-2-HYDROXY-5,5-DIMETHYL-1,3,2-DIOXAPHOSPHORINANE2-OXIDE

C19H21NO2 (295.1572206)


   

3-morpholin-4-yl-1,2-diphenylpropan-1-one

3-morpholin-4-yl-1,2-diphenylpropan-1-one

C19H21NO2 (295.1572206)


   

1-benzyl-4-phenylpiperidine-4-carboxylic acid

1-benzyl-4-phenylpiperidine-4-carboxylic acid

C19H21NO2 (295.1572206)


   
   

tert-Butyl 2-((diphenylmethylene)amino)acetate

tert-Butyl 2-((diphenylmethylene)amino)acetate

C19H21NO2 (295.1572206)


   

(4-(Benzyloxy)phenyl)(piperidin-4-yl)Methanone

(4-(Benzyloxy)phenyl)(piperidin-4-yl)Methanone

C19H21NO2 (295.1572206)


   

ethyl 1-benzhydrylazetidine-2-carboxylate

ethyl 1-benzhydrylazetidine-2-carboxylate

C19H21NO2 (295.1572206)


   

Beloxepin

Beloxepin

C19H21NO2 (295.1572206)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent

   

3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

3-Allyl-2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine

C19H21NO2 (295.1572206)


D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018491 - Dopamine Agonists

   

(6aS)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

(6aS)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

C19H21NO2 (295.1572206)


   

3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone

3,4-dihydro-2H-quinolin-1-yl-(4-propoxyphenyl)methanone

C19H21NO2 (295.1572206)


   

Nuciferin

4H-Dibenzo(de,g)quinoline, 5,6,6a,7-tetrahydro-1,2-dimethoxy-6-methyl-, (R)- (9CI)

C19H21NO2 (295.1572206)


Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor. Nuciferine is an antagonist at 5-HT2A (IC50=478 nM), 5-HT2C (IC50=131 nM), and 5-HT2B (IC50=1 μM), an inverse agonist at 5-HT7 (IC50=150 nM), a partial agonist at D2 (EC50=64 nM), D5 (EC50=2.6 μM) and 5-HT6 (EC50=700 nM), an agonist at 5-HT1A (EC50=3.2 μM) and D4 (EC50=2 μM) receptor.

   

3-[3-(4-isopropylphenyl)acryloyl]-4,6-dimethyl-2(1H)-pyridinone

3-[3-(4-isopropylphenyl)acryloyl]-4,6-dimethyl-2(1H)-pyridinone

C19H21NO2 (295.1572206)


   

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

2-[[2-(4-Hydroxyphenyl)ethylamino]methyl]-3,4-dihydro-2H-naphthalen-1-one

C19H21NO2 (295.1572206)


D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists

   

(E)-2-hydroxydoxepin

(E)-2-hydroxydoxepin

C19H21NO2 (295.1572206)


   
   

(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

(8R)-7-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-13,14-diol

C19H21NO2 (295.1572206)